Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells
about
Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAsRecruitment of the complete hTREX complex is required for Kaposi's sarcoma-associated herpesvirus intronless mRNA nuclear export and virus replicationKaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways.Actin dynamics regulate multiple endosomal steps during Kaposi's sarcoma-associated herpesvirus entry and trafficking in endothelial cellsThe ubiquitin/proteasome system mediates entry and endosomal trafficking of Kaposi's sarcoma-associated herpesvirus in endothelial cellsHost and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus.Regulation of microfilament organization by Kaposi sarcoma-associated herpes virus-cyclin.CDK6 phosphorylation of caldesmon.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells.Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.Robust inference of the context specific structure and temporal dynamics of gene regulatory networkActivation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50).Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latencyA hydrophobic domain within the small capsid protein of Kaposi's sarcoma-associated herpesvirus is required for assembly.Kaposi's sarcoma-associated herpesvirus virion-induced transcription activation of the ORF50 immediate-early promoterKaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication.Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCĪ³1 and activating NFAT1-dependent RCAN1 expression.Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription.Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection.JNK1 is required for lentivirus entry and gene transferMechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and ReactivationMolecular biology of KSHV lytic reactivation.KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathwaysMolecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesisPathology of Kaposi's Sarcoma-Associated Herpesvirus InfectionKaposi's Sarcoma-Associated Herpesvirus Genome Replication, Partitioning, and Maintenance in Latency.Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acidDirect and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHVKaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNsKaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases.A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathwaysKaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency.Human Mesenchymal Stem Cells of Diverse Origins Support Persistent Infection with Kaposi's Sarcoma-Associated Herpesvirus and Manifest Distinct Angiogenic, Invasive, and Transforming Phenotypes.Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherinPhosphorylation of Kaposi's sarcoma-associated herpesvirus processivity factor ORF59 by a viral kinase modulates its ability to associate with RTA and oriLyt.Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent declin
P2860
Q24309306-098EB739-77A9-4BA5-84C6-6C89D9C0DAD8Q24310689-2A16154E-02AC-4CF7-8EDB-8BC96DC20FE8Q24534690-465CC60A-D692-4AF8-8C16-A64F2DF17BC4Q27316598-A844448C-07EE-4FA1-A328-54730D9DB804Q27345534-0466EFFF-50B0-4CAA-B954-DA4457671A73Q31156919-5D57BBE7-34A1-49CD-A9A0-F9332506FA7BQ33222108-E3BA0789-F978-431D-B26E-62A494F427F1Q33560572-7E1F8218-9F94-43BE-A65E-50FE821E92C3Q33623056-47707939-E5B9-414D-B259-54DAF263A387Q33667093-17F6F5E7-B683-43D1-99C0-B33A68547999Q33744019-CAE45D67-0EB6-4C3B-9A01-F5FF993DA406Q33766577-1F648013-FE64-498B-BB3C-5B2015ED35FBQ33843421-63C5516F-FCE7-4206-AF3A-2A6D69F9F2EBQ33887681-AA49E157-38A8-4F01-AE25-24286B56CDF3Q33916507-FD828844-94F2-4568-A75A-5EAA0B1576E5Q33918642-B812DA7F-FA7B-493B-B4E6-E276EA6180A1Q34045753-EEA7373A-3BD7-421E-87F2-4B6E2B9A820CQ34261905-D8F3C6DD-4223-4F8B-BE1E-790CB63CB6A8Q34426472-7EA4FA6C-9910-48F9-97FE-9CC67AE601D0Q34648229-A450952B-7BF4-478E-A22A-570FEB2336F8Q34648384-DAFE0080-40D8-4578-BAD3-CABA2C93258BQ34742984-DADA648C-175C-4277-B07F-82E14A84AEF2Q35010647-4578590B-3158-4BA2-B6B1-CB908B5C7572Q35014918-714FE2E0-F2BD-4E19-B592-C93B93BB3B92Q35079842-8BAA9070-585B-457F-8C5A-96F49888F094Q35124404-6484F6CC-7A52-4CBE-A26C-054889587FC0Q35179783-55DA2D70-89C2-45CA-A83B-BCC65252704AQ35691156-CB366FAC-514A-470F-B649-A7A822BA248FQ35702343-4D38B68A-6448-4E7B-89EC-737A7EC74568Q35780222-7EF62100-9BB8-4921-845E-423BB6458441Q35785255-86437A50-8688-4DC5-B812-B2EF64CF9366Q35808893-8C59B1DA-66C1-42D4-A32B-E897BFC59B41Q35914351-FE66BCC9-1F69-4C61-A88B-F4C69951C663Q35983671-5D07954A-2010-410F-80A0-17514B8D47A7Q36454456-6D334BE3-0B16-45DE-9057-1D29E130A80AQ36540187-7773DEB6-EF79-4BD8-A968-455846A8D8FEQ36548258-D9A6BA1B-A77C-46AF-A1FB-694D4BCEF150Q36974720-FD03C52C-AA47-4B3F-94C3-796B72AB9D32Q36978654-56A24E44-5460-4ED1-B720-DA883AA26906Q37010247-C81CFD36-93EF-4FF7-AA22-CEDFC1A769BF
P2860
Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells
description
2003 nĆ® lÅ«n-bĆ»n
@nan
2003幓ć®č«ę
@ja
2003幓å¦ęÆęē«
@wuu
2003幓å¦ęÆęē«
@zh-cn
2003幓å¦ęÆęē«
@zh-hans
2003幓å¦ęÆęē«
@zh-my
2003幓å¦ęÆęē«
@zh-sg
2003幓åøč”ęē«
@yue
2003幓åøč”ęē«
@zh
2003幓åøč”ęē«
@zh-hant
name
Productive lytic replication o ...... rimary human endothelial cells
@en
Productive lytic replication o ...... imary human endothelial cells.
@nl
type
label
Productive lytic replication o ...... rimary human endothelial cells
@en
Productive lytic replication o ...... imary human endothelial cells.
@nl
prefLabel
Productive lytic replication o ...... rimary human endothelial cells
@en
Productive lytic replication o ...... imary human endothelial cells.
@nl
P2860
P1433
P1476
Productive lytic replication o ...... rimary human endothelial cells
@en
P2093
Fu-Chun Zhou
Jian-Hong Deng
P2860
P304
P356
10.1128/JVI.77.18.9738-9749.2003
P407
P577
2003-09-01T00:00:00Z